Monthly Prescribing Reference27d
Pentavalent Meningococcal Vaccine Penmenvy Gets FDA Approval
Noninferiority was observed with Penmenvy vs 2 doses of Bexsero for the proportion of ... with a single dose of Menveo in both MenACWY vaccine-naïve participants and MenACWY vaccine-experienced ...
WebMD11d
FDA Approves 5-in-1 Vaccine Against Meningococcal Disease
Penmenvy combines parts of the well-established Bexsero and Menveo vaccines into a single shot, protecting against the five most common strains of Neisseria meningitidis (A, B, C, W, and Y).
Healio28d
FDA approves GSK’s pentavalent meningococcal vaccine
The vaccine, branded as Penmenvy, combines components from two of GSK’s existing vaccines: Bexsero, which protects against serogroup B; and Menveo, which protects against serogroup A ...
Morningstar27d
PENMENVY, GSK’s 5-in-1 Meningococcal Vaccine, Approved by US FDA to Help Protect Against MenABCWY
Vaccine helps protect against five common disease ... Important Safety Information for BEXSERO in the US The following is based on the US Prescribing Information for BEXSERO.
Hosted on MSN26d
FDA Approves More Broadly Protective Meningococcal Vaccine
The vaccine is an injectable suspension for intramuscular use that combines components of GSK's two well-established meningococcal vaccines, Bexsero and Menveo.
U.S. News & World Report26d
FDA Approves More Broadly Protective Meningococcal Vaccine
TUESDAY, Feb. 18, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active immunization against invasive ...
Benzinga.com26d
FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week
The FDA approved GSK's Penmenvy vaccine for ages 10-25, targeting five major meningococcal serogroups: A, B, C, W, and Y. Phase 3 trials with 4,800 participants showed the vaccine has a safety ...
scmp.com29d
FDA approves GSK vaccine to combat meningococcal infections
combines the immune response-generating components of two of the company’s approved vaccines, Bexsero and Menveo, to protect against the five most common strains of meningococcal bacteria ...
Pharmabiz27d
GSK’s 5-in-1 meningococcal vaccine, Penmenvy receives US FDA approval to help protect against MenABCWY
The vaccine combines the antigenic components of GSK’s two well-established meningococcal vaccines, Bexsero (Meningococcal Group B Vaccine) and Menveo (Meningococcal [Groups A, C, Y, and W-135] ...
PMLiVE28d
GSK’s five-in-one meningococcal vaccine Penmenvy granted FDA approval
GSK’s Penmenvy combines the antigenic components of its approved Bexsero and Menveo meningococcal vaccines to target five common IMD-causing serotypes (A, B, C, W and Y). It is hoped that the ...
Nasdaq27d
FDA Approves GSK's Penmenvy, 5-in-1 Meningococcal Vaccine For MenABCWY Protection
(RTTNews) - GSK plc (GSK, GSK.L) announced that the US Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for use in individuals aged 10 through 25 ...